HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Moderna flu vaccine wins unanimous support from FDA panel

The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.

By BioPharma Dive · Jun 18, 2026 · via BioPharma Dive
Moderna flu vaccine wins unanimous support from FDA panel

Image: BioPharma Dive

This is an aggregated industry headline. Read the full story at BioPharma Dive

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineBioPharma Dive
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Before Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to dive…
Jun 19, 2026
Moderna's flu candidate sails through FDA advisory committee in unanimous votes
The WeekFierceBiotech ↗
As Moderna reshapes itself in the wake of the pandemic, the company on Thursday passed a key milestone in its …
Jun 19, 2026
Verastem pivots after modest pancreatic cancer data
The WeekBriefing
The company will steer R&D toward other pipeline priorities after updated results for its approved combo fell …
Jun 19, 2026